Literature DB >> 18026113

A pivotal role for galectin-1 in fetomaternal tolerance.

Sandra M Blois1, Juan M Ilarregui, Mareike Tometten, Mariana Garcia, Arif S Orsal, Rosalia Cordo-Russo, Marta A Toscano, Germán A Bianco, Peter Kobelt, Bori Handjiski, Irene Tirado, Udo R Markert, Burghard F Klapp, Francoise Poirier, Julia Szekeres-Bartho, Gabriel A Rabinovich, Petra C Arck.   

Abstract

A successful pregnancy requires synchronized adaptation of maternal immune-endocrine mechanisms to the fetus. Here we show that galectin-1 (Gal-1), an immunoregulatory glycan-binding protein, has a pivotal role in conferring fetomaternal tolerance. Consistently with a marked decrease in Gal-1 expression during failing pregnancies, Gal-1-deficient (Lgals1-/-) mice showed higher rates of fetal loss compared to wild-type mice in allogeneic matings, whereas fetal survival was unaffected in syngeneic matings. Treatment with recombinant Gal-1 prevented fetal loss and restored tolerance through multiple mechanisms, including the induction of tolerogenic dendritic cells, which in turn promoted the expansion of interleukin-10 (IL-10)-secreting regulatory T cells in vivo. Accordingly, Gal-1's protective effects were abrogated in mice depleted of regulatory T cells or deficient in IL-10. In addition, we provide evidence for synergy between Gal-1 and progesterone in the maintenance of pregnancy. Thus, Gal-1 is a pivotal regulator of fetomaternal tolerance that has potential therapeutic implications in threatened pregnancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18026113     DOI: 10.1038/nm1680

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  180 in total

1.  IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells.

Authors:  Fang Zhou; Bogoljub Ciric; Hongmei Li; Yaping Yan; Ke Li; Melissa Cullimore; Elisabetta Lauretti; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Eur J Immunol       Date:  2012-05-23       Impact factor: 5.532

2.  Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.

Authors:  JoonHo Lee; Roberto Romero; Yi Xu; Jung-Sun Kim; Ji Young Park; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Reprod Immunol       Date:  2011-09-27       Impact factor: 3.886

3.  Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict.

Authors:  Robert M Samstein; Steven Z Josefowicz; Aaron Arvey; Piper M Treuting; Alexander Y Rudensky
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

Review 4.  Interaction of extravillous trophoblast galectin-1 and mucin(s)-Is there a functional relevance?

Authors:  Žanka Bojić-Trbojević; Milica Jovanović Krivokuća; Nikola Kolundžić; Toshihiko Kadoya; Ljiljana Radojčić; Ljiljana Vićovac
Journal:  Cell Adh Migr       Date:  2015-09-29       Impact factor: 3.405

5.  Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice.

Authors:  Antoine L Perchellet; Susmita Jasti; Margaret G Petroff
Journal:  Biol Reprod       Date:  2013-10-31       Impact factor: 4.285

Review 6.  Overview of the immune response.

Authors:  David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

7.  Suppression of autoimmune diabetes by soluble galectin-1.

Authors:  Marcelo J Perone; Suzanne Bertera; William J Shufesky; Sherrie J Divito; Angela Montecalvo; Alicia R Mathers; Adriana T Larregina; Mabel Pang; Nilufer Seth; Kai W Wucherpfennig; Massimo Trucco; Linda G Baum; Adrian E Morelli
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand.

Authors:  Mirian Mendoza; Dongli Lu; Angela Ballesteros; Sandra M Blois; Kelsey Abernathy; Chiguang Feng; Charles J Dimitroff; Jonathan Zmuda; Maria Panico; Anne Dell; Gerardo R Vasta; Stuart M Haslam; Gabriela Dveksler
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

9.  Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain.

Authors:  Sean R Stowell; Connie M Arthur; Kristin A Slanina; John R Horton; David F Smith; Richard D Cummings
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

10.  Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Authors:  Fang Zhou; Elisabetta Lauretti; Antonio di Meco; Bogoljub Ciric; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunobiology       Date:  2013-03-01       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.